KRAS and neoplasm: The original study by Gasparini et al. showed that the tissue expression level of miR-504 was significantly reduced in KRAS-mutated tumours (normalised expression level of 1.6) with respect to EGFR-mutated tumours (normalised expression level of 4.1; p < 0.0001) [31].